With more than 25 years of experience, William Hagstrom stands as a leader in the healthcare industry.

He is currently the chief executive officer of Crescendo Bioscience, a molecular diagnostics laboratory headquartered in South San Francisco, CA. Focusing its chief research on rheumatoid arthritis, Crescendo Bioscience aims to "develop objective molecular tests to provide rheumatologists with deeper clinical insights into biology, to help enable more effective management of patients with autoimmune and inflammatory diseases," according to the company's Web site. Its researchers presented three studies reporting on the "successive refinement of statistical models to associate candidate serum protein biomarkers with the severity of RA disease activity" at the 73rd annual meeting of the American College of Rheumatology in October 2009. By demonstrating "superior predictive value of a multi-protein biomarker index as compared to any single measure," the research, as reported on ...

Go to complete bio »
Speaker's website »